China Isotope & Radiation Corporation
HKEX:1763.HK
9.59 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,634.992 | 6,146.172 | 5,143.694 | 4,274.183 | 3,988.904 | 3,238.019 | 2,672.045 | 2,363.122 | 2,152.134 |
| Cost of Revenue
| 3,152.753 | 2,631.493 | 1,901.79 | 1,658.196 | 1,159.577 | 945.471 | 787.259 | 698.762 | 664.934 |
| Gross Profit
| 3,482.239 | 3,514.679 | 3,241.904 | 2,615.987 | 2,829.327 | 2,292.548 | 1,884.786 | 1,664.36 | 1,487.2 |
| Gross Profit Ratio
| 0.525 | 0.572 | 0.63 | 0.612 | 0.709 | 0.708 | 0.705 | 0.704 | 0.691 |
| Reseach & Development Expenses
| 306.051 | 300.51 | 196.214 | 152.531 | 102.717 | 73.035 | 73.452 | 58.717 | 44.579 |
| General & Administrative Expenses
| 635.914 | 573.463 | 497.984 | 451.567 | 509.268 | 401.902 | 296.014 | 258.304 | 234.323 |
| Selling & Marketing Expenses
| 1,768.368 | 1,787.952 | 1,820.458 | 1,442.556 | 1,687.501 | 1,302.267 | 1,094.684 | 933.902 | 810.75 |
| SG&A
| 2,404.282 | 2,394.283 | 2,331.2 | 1,918.072 | 2,178.965 | 1,704.169 | 1,390.698 | 1,192.206 | 1,045.073 |
| Other Expenses
| 17.699 | 11.826 | 14.14 | 11.533 | 5.872 | 8.703 | 6.691 | 7.052 | 5.721 |
| Operating Expenses
| 2,677.707 | 2,613.134 | 2,436.178 | 2,021.894 | 2,126.01 | 1,697.918 | 1,377.821 | 1,183.294 | 1,039.474 |
| Operating Income
| 941.598 | 873.66 | 742.85 | 580.551 | 670.006 | 676.652 | 530.053 | 498.361 | 462.608 |
| Operating Income Ratio
| 0.142 | 0.142 | 0.144 | 0.136 | 0.168 | 0.209 | 0.198 | 0.211 | 0.215 |
| Total Other Income Expenses Net
| 172.758 | 46.851 | 59.828 | 15.612 | 63.801 | 16.482 | 27.911 | 14.388 | 23.226 |
| Income Before Tax
| 922.437 | 920.511 | 802.678 | 596.163 | 733.807 | 693.134 | 557.964 | 512.749 | 485.834 |
| Income Before Tax Ratio
| 0.139 | 0.15 | 0.156 | 0.139 | 0.184 | 0.214 | 0.209 | 0.217 | 0.226 |
| Income Tax Expense
| 146.307 | 165.947 | 129.641 | 120.64 | 108.882 | 105.076 | 82.326 | 78.247 | 75.452 |
| Net Income
| 370.967 | 392.275 | 335.751 | 213.582 | 329.03 | 322.951 | 271.454 | 262.108 | 254.205 |
| Net Income Ratio
| 0.056 | 0.064 | 0.065 | 0.05 | 0.082 | 0.1 | 0.102 | 0.111 | 0.118 |
| EPS
| 1.16 | 1.22 | 1.05 | 0.67 | 1.03 | 1.16 | 1.13 | 0.82 | 0.79 |
| EPS Diluted
| 1.16 | 1.22 | 1.05 | 0.67 | 1.03 | 1.16 | 1.13 | 0.82 | 0.79 |
| EBITDA
| 1,135.742 | 1,054.25 | 901.432 | 717.433 | 770.305 | 774.492 | 634.03 | 588.789 | 548.235 |
| EBITDA Ratio
| 0.171 | 0.172 | 0.175 | 0.168 | 0.193 | 0.239 | 0.237 | 0.249 | 0.255 |